Fundz

Argo Biopharma Appoints Gena Wang as Chief Financial Officer and Chief Strategy Officer

PRIVATEMar 02, 2026

Position

Chief Strategy Officer

Company

Argo Biopharmaceutical Ltd

Gena Wang
ChinaBiotechnologyHealth CareTherapeutics

Description

Argo Biopharma announced the appointment of Gena Wang, Ph.D., CFA, as Chief Financial Officer and Chief Strategy Officer, effective March 1, 2026. She brings nearly 20 years of Wall Street sell-side experience in biotechnology to the company.

Quick answer

Argo Biopharma Appoints Gena Wang as Chief Financial Officer and Chief Strategy Officer (March 2, 2026). Argo Biopharmaceutical Ltd is based in China.

Who is the new Chief Strategy Officer at Argo Biopharmaceutical Ltd?
Argo Biopharmaceutical Ltd named Gena Wang Chief Strategy Officer, announced March 2, 2026.
What did Argo Biopharmaceutical Ltd announce on March 2, 2026?
Argo Biopharma announced the appointment of Gena Wang, Ph.D., CFA, as Chief Financial Officer and Chief Strategy Officer, effective March 1, 2026. She brings nearly 20 years of Wall Street sell-side experience in biotechnology to the company.
What does Argo Biopharmaceutical Ltd do?
Founded in April 2021, Argo is a privately held biotechnology company based in Shanghai.
Where is Argo Biopharmaceutical Ltd based?
Argo Biopharmaceutical Ltd is based in China.
Which similar companies made leadership changes around the same time?
Seres Therapeutics (March 2, 2026), Royalty Pharma plc (March 3, 2026), Pulse Biosciences, Inc. (February 27, 2026) and XyloCor Therapeutics (March 5, 2026) also announced leadership changes within 45 days of Argo Biopharmaceutical Ltd.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Argo Biopharmaceutical Ltd, and when

A new leader at Argo Biopharmaceutical Ltd brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Argo Biopharmaceutical Ltd raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Argo Biopharmaceutical Ltd, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Argo Biopharmaceutical Ltd. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Argo Biopharmaceutical Ltd

Location

China

About

Founded in April 2021, Argo is a privately held biotechnology company based in Shanghai. The company's primary focus is on RNAi drug research and development. Argo has developed industry-leading RNAi platform technology named RADS (RNAi molecules with superior Activity, Duration and Safety), which embodies Argo's technological prowess in delivery, chemical modification, and sequence designs, consistently yielding top-tier RNAi therapeutics. Argo's present pipeline includes more than 20 therapeutic programs for the treatment of cardiovascular and metabolic diseases, hematology, complement pathway diseases, viral infection and neurodegenerative diseases. Five leading programs are in the clinical development stage, and all have demonstrated well-tolerated safety profiles and best-in-class potential. Additional information about Argo is available at www.argobiopharma.com. SOURCE Shanghai Argo Biopharmaceutical Co., Ltd.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Argo Biopharmaceutical Ltd changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Argo Biopharmaceutical Ltd's next move

Learn about Strategic plan

Argo Biopharmaceutical Ltd changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.